Skip to main content

Table 1 Sample characteristics

From: MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study

  Total Male Female
N = 12 n = 8 n = 4
Demographics
Age
 Mean (± SD) 31.33 (2.84) 31.13 (3.44) 31.75 (1.26)
 [Range] years [26–36] [26–36] [25–33]
Ethnicity, n (%)
 White 11 (91.7) 7 (87.5) 4 (100)
 Other 1 (8.3) 1 (12.5) 0 (0)
Marital status, n (%)
 Single, never married 10 (83.3) 6 (75.0) 4 (100)
 Married 2 (16.7) 2 (25.0) 0 (0)
Education, n (%)
 Some high school 3 (25.0) 3 (37.5) 0 (0)
 High school graduate or GED 5 (41.7) 3 (37.5) 2 (50.0)
 Some college or trade school 4 (33.3) 2 (25.0) 2 (50.0)
Employment, n (%)
 Employed 7 (58.3) 6 (75.0) 1 (25.0)
 Unemployed 5 (41.7) 2 (25.0) 3 (75.0)
Comorbid mental health disorder
Depression, n (%)
 Hx major depressive episode 5 (41.7) 3 (37.5) 2 (50.0)
Anxiety, n (%)
 Any anxiety disorder 7 (58.3) 4 (50.0) 3 (75.0)
PTSD, n (%)
 Subset of anxiety 3 (25.0) 2 (25.0) 1 (25.0)
Recent illicit substance use
Cocaine, n (%)
 30 days prior to baseline 4 (33.3) 4 (50.0) 0 (0)
Benzodiazepines, n (%)
 30 days prior to baseline 7 (58.3) 3 (37.5) 4 (100)
Technology use
Videoconference, n (%)
 Any use before study 4 (33.3) 4 (50.0) 0 (0)
Smartphone, n (%)
 Any use before study 12 (100) 8 (100) 4 (100)